cml biology for the clinician in 2011: six impossible things to believe before breakfast on the way to cure

Por Leber, B.
Publicado em 2011

Structure of plant nuclear and ribosomal DNA containing chromatin.

Por Leber, B, Hemleben, V
Publicado em 1979

Optimizing outcomes with azacitidine: recommendations from Canadian centres of excellence

Por Wells, R.A., Leber, B., Zhu, N.Y., Storring, J.M.
Publicado em 2014

Targeting of passenger protein domains to multiple intracellular membranes.

Por Janiak, F, Glover, J R, Leber, B, Rachubinski, R A, Andrews, D W
Publicado em 1994

Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types.

Por Zhu, W, Cowie, A, Wasfy, G W, Penn, L Z, Leber, B, Andrews, D W
Publicado em 1996

Multiple partners can kiss-and-run: Bax transfers between multiple membranes and permeabilizes those primed by tBid

Por Shamas-Din, A, Satsoura, D, Khan, O, Zhu, W, Leber, B, Fradin, C, Andrews, D W
Publicado no Cell Death Dis (2014)

Interactions of endotoxin, albumin function, albumin binding capacity and oxidative stress in brain-dead organ donors

Por Stadlbauer, V, Leber, B, Stiegler, P, Stanzer, S, Mayrhauser, U, Köstenbauer, S, Sereinigg, M, Puntschart, A, Stojakovic, T, Tscheliessnigg, K, Oettl, K
Publicado em 2011

Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with Philadelphia chromosome–positive or BCR-ABL–positive acute lymphoblastic leukemia: a Canadian con...

Por Couban, S., Savoie, L., Mourad, Y. Abou, Leber, B., Minden, M., Turner, R., Palada, V., Shehata, N., Christofides, A., Lachance, S.
Publicado em 2014

A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adults

Por Seftel, M.D., Barnett, M.J., Couban, S., Leber, B., Storring, J., Assaily, W., Fuerth, B., Christofides, A., Schuh, A.C.
Publicado em 2014

Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis

Por Horvath, A., Leber, B., Schmerboeck, B., Tawdrous, M., Zettel, G., Hartl, A., Madl, T., Stryeck, S., Fuchs, D., Lemesch, S., Douschan, P., Krones, E., Spindelboeck, W., Durchschein, F., Rainer, F., Zollner, G., Stauber, R. E., Fickert, P., Stiegler, P., Stadlbauer, V.
Publicado no Aliment Pharmacol Ther (2016)

Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results

Por Hughes, T P, Leber, B, Cervantes, F, Spector, N, Pasquini, R, Clementino, N C D, Schwarer, A P, Dorlhiac-Llacer, P E, Mahon, F-X, Rea, D, Guerci-Bresler, A, Kamel-Reid, S, Bendit, I, Acharya, S, Glynos, T, Dalal, D, Branford, S, Lipton, J H
Publicado no Leukemia (2017)

Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia

Por DeAngelo, D J, Stevenson, K E, Dahlberg, S E, Silverman, L B, Couban, S, Supko, J G, Amrein, P C, Ballen, K K, Seftel, M D, Turner, A R, Leber, B, Howson-Jan, K, Kelly, K, Cohen, S, Matthews, J H, Savoie, L, Wadleigh, M, Sirulnik, L A, Galinsky, I, Neuberg, D S, Sallan, S E, Stone, R M
Publicado no Leukemia (2015)